Framework agreement for CAR-T cell therapy active ingredients
Original notice title
Italy – Antineoplastic and immunomodulating agents – GARA EUROPEA A PROCEDURA APERTA PER LA FORNITURA, IN ACCORDO QUADRO MULTIFORNITORE, DI PRINCIPI ATTIVI PER TERAPIE CON CELLULE CAR-T DESTINATE A PAZIENTI IN CARICO ALL’AZIENDA ULSS N. 8 BERICA
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
60 / 100
Risk factors
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 19.4M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 12 MONTH
- Supply of active principles (pharmaceutical substances) for CAR-T cell therapies.
- The products are intended for specific lymphoma indications: DLBCL (2nd and 3rd line), PMBCL (3rd line), and follicular lymphoma (4th line).
Show full summary
This is an open procedure tender for a multi-supplier framework agreement for the supply of active principles for CAR-T cell therapies, intended for patients under the care of Azienda ULSS n. 8 Berica (Italy). The tender is divided into three lots covering specific lymphoma therapies. The procedure is currently suspended due to a complaint (reclamo) as per the XML notice. The estimated total value across lots is €19,401,945. Award is based solely on price. Submission deadline is 2026-07-06 (10:00 or 12:00 – inconsistency noted). Important documents (e.g., ESPD) are required. EU funding status is inconsistent between structured data (EU-funded) and XML notice (no EU funds). The notice is in Italian only.
Risks
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Certifications
- All communications and submissions must be electronic via Sintel or certified email (PEC) for Italian operators, or qualified electronic registered delivery service for...
Administrative
- Registration on the Sintel e-procurement platform (ARIA SPA) is mandatory.
- Tender must be accompanied by the European Single Procurement Document (ESPD) or equivalent.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Buyer
Location
Vicenza, ITA
Website
Buyer profile
Identifier
02441500242
Activity
Health
Lots (3)
LOT-0001
LOTTO 1 - Therapy for adult patients with DLBCL Lymphoma - 2nd Line and Therapy for adult patients with PMBCL Lymphoma - 3rd Line
Supply of active principles for CAR-T therapy for adult patients with DLBCL (2nd line) and PMBCL (3rd line). Framework agreement with a maximum value of €15,936,345, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Lowest price
Value note
Framework maximum value
Show original TED data
Original lot title
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
Original TED description
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
LOT-0002
LOTTO 2 - Therapy for adult patients with DLBCL Lymphoma - 3rd Line
Supply of active principles for CAR-T therapy for adult patients with DLBCL (3rd line). Framework agreement with a maximum value of €1,732,800, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Lowest price
Value note
Framework maximum value
Show original TED data
Original lot title
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
Original TED description
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
LOT-0003
LOTTO 3 - Therapy for adult patients with Follicular Lymphoma (FL) - 4th Line
Supply of active principles for CAR-T therapy for adult patients with follicular lymphoma (4th line). Framework agreement with a maximum value of €1,732,800, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Lowest price
Value note
Framework maximum value
Show original TED data
Original lot title
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Original TED description
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Procurement Details
- Publication date
- 02 Jul 2026
- Languages
- Italian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 456933-2026
Documents (2)
Similar tenders
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
60 / 100
Risk factors
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications